SingleBioregulators

Prostamax 20mg

Synthetic KEDP tetrapeptide bioregulator investigated for its hypothesized epigenetic modulation and support of prostate tissue.

Mechanism

Proposed to interact directly with chromatin structures to influence gene transcription and protein synthesis pathways specific to prostatic cells.

Dosing

Standard laboratory reference protocols document a starting quantity of 500 mcg administered once daily, with gradual upward titration over a 12-week framework.

Reconstitution

Adding 3.0 mL of bacteriostatic water to a 20 mg vial yields an approximate working concentration of 6.67 mg/mL (6,667 mcg/mL).

Storage

Store the lyophilized vial frozen at -20 °C, and keep the reconstituted solution refrigerated at 2–8 °C away from light without freezing.

Mix & measure Prostamax 20mg

Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.

Mix & measure Prostamax 20mg

Vial strength → BAC water → target dose

Vial strength

BAC water

Target dose

Concentration6.67mg/mL

Draw volume0.075mL

On the syringe7.50units

Total doses in vial: 40.0

100u80u60u40u20u0

U-100 syringe: 100 units = 1 mL

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →

Dosing Chart

Phase / Day(s)	Dose & Frequency	Volume (U-100 units / mL)
Weeks 1–2	500 mcg (1× daily)	7.5 units (~0.075 mL)
Weeks 3–4	1,000 mcg (1× daily)	15 units (0.15 mL)
Weeks 5–6	2,000 mcg (1× daily)	30 units (0.30 mL)
Weeks 7–12	3,000 mcg (1× daily)	45 units (0.45 mL)

Reconstitution Steps

1
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
2
Release it slowly down the vial's inner wall to limit foaming.
3
Swirl or roll gently until fully dissolved — don't shake.
4
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.

Supplies Needed

Peptide Vial

Prostamax 20 mg lyophilized powder vial for reconstitution.

Insulin Syringes (U-100)

Calibrated 1 mL syringes used to accurately draw and measure low-volume doses.

Bacteriostatic Water

Sterile diluent containing 0.9% benzyl alcohol used to reconstitute the peptide cake.

Alcohol Swabs

Used to disinfect the vial rubber stopper and clean laboratory preparation areas.

Why researchers study it

Prostate health & function

Prostatitis & inflammation

Lower urinary tract function

Male reproductive support

These describe what is being studied, not proven benefits, approved uses, or promised results.

Overview

Prostamax is a synthetic peptide bioregulator consisting of the four-amino-acid sequence Lys-Glu-Asp-Pro (KEDP). Originating from the Khavinson short-peptide research framework, it was conceptualized as a targeted, chemically defined counterpart to complex organ extracts historically derived from bovine prostate tissue. In experimental models, short bioregulatory peptides are studied for their potential tissue-specific cellular interactions. Preclinical research explores the peptide within the context of prostate cellular biology, inflammatory pathways, and age-related tissue changes. However, empirical human data and Western randomized controlled trials remain lacking, and the sequence should not be conflated with registered pharmaceutical bovine extracts. Consequently, Prostamax is handled strictly as an unapproved research compound for laboratory investigations.

References

1.Khavinson V.Kh. et al., PubMed, 2020 — Overview of Khavinson short-peptide bioregulators and the KEDP tetrapeptide
2.Khavinson V.Kh. et al., Bulletin of Experimental Biology and Medicine, 2014 — Peptide-DNA interactions and chromatin modulation
3.Russian Clinical Studies, Preclinical Archive, 2018 — Preclinical evaluation of prostate short regulatory peptides in animal models